(NYSE: PFE) Pfizer's forecast annual revenue growth rate of 2.17% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.16%.
Pfizer's revenue in 2024 is $58,496,000,000.On average, 6 Wall Street analysts forecast PFE's revenue for 2024 to be $340,265,144,138,052, with the lowest PFE revenue forecast at $335,002,809,681,783, and the highest PFE revenue forecast at $343,617,760,718,100. On average, 6 Wall Street analysts forecast PFE's revenue for 2025 to be $350,515,859,595,302, with the lowest PFE revenue forecast at $347,042,983,575,137, and the highest PFE revenue forecast at $354,916,964,346,525.
In 2026, PFE is forecast to generate $350,626,824,438,131 in revenue, with the lowest revenue forecast at $346,040,341,597,994 and the highest revenue forecast at $360,456,453,981,450.